Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease

D Trabattoni, M Saresella, M Pacei… - The Journal of …, 2009 - journals.aai.org
T lymphocytes costimulatory molecules, including CD80, CD86, CD28, CTLA4, PD-1, PD-
L1, and B7-H3, are associated with the preferential production of pro-or anti-inflammatory …

[PDF][PDF] Costimulatory Pathways in Multiple Sclerosis: Distinctive Expression of PD-1 and PD-L1 in Patients with Different Patterns of Disease

D Trabattoni, M Saresella, M Pacei, I Marventano… - J Immunol, 2009 - academia.edu
T lymphocytes costimulatory molecules, including CD80, CD86, CD28, CTLA4, PD-1, PD-
L1, and B7-H3, are associated with the preferential production of pro-or anti-inflammatory …

Costimulatory Pathways in Multiple Sclerosis: Distinctive Expression of PD-1 and PD-L1 in Patients with Different Patterns of Disease

D Trabattoni, M Saresella, M Pacei… - The Journal of …, 2009 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> T lymphocytes costimulatory molecules,
including CD80, CD86, CD28, CTLA4, PD-1, PD-L1, and B7-H3, are associated with the …

Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease

D Trabattoni, M Saresella, M Pacei… - Journal of …, 2009 - pubmed.ncbi.nlm.nih.gov
T lymphocytes costimulatory molecules, including CD80, CD86, CD28, CTLA4, PD-1, PD-
L1, and B7-H3, are associated with the preferential production of pro-or anti-inflammatory …

Costimulatory Pathways in Multiple Sclerosis: Distinctive Expression of PD-1 and PD-L1 in Patients with Different Patterns of Disease

D Trabattoni, M Saresella, M Pacei… - The Journal of …, 2009 - journals.aai.org
T lymphocytes costimulatory molecules, including CD80, CD86, CD28, CTLA4, PD-1, PD-
L1, and B7-H3, are associated with the preferential production of pro-or anti-inflammatory …

Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.

D Trabattoni, M Saresella, M Pacei… - … (Baltimore, Md.: 1950 …, 2009 - europepmc.org
T lymphocytes costimulatory molecules, including CD80, CD86, CD28, CTLA4, PD-1, PD-
L1, and B7-H3, are associated with the preferential production of pro-or anti-inflammatory …

Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease

D Trabattoni, M Saresella, M Pacei… - JOURNAL OF …, 2009 - air.unimi.it
T lymphocytes costimulatory molecules, including CD80, CD86, CD28, CTLA4, PD-1, PD-
L1, and B7-H3, are associated with the preferential production of pro-or anti-inflammatory …

Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.

D Trabattoni, M Saresella, M Pacei, I Marventano… - 2009 - cabidigitallibrary.org
T lymphocytes costimulatory molecules, including CD80, CD86, CD28, CTLA4, PD-1, PD-
L1, and B7-H3, are associated with the preferential production of pro-or anti-inflammatory …

[引用][C] Costimulatory Pathways in Multiple Sclerosis: Distinctive Expression of PD-1 and PD-L1 in Patients with Different Patterns of Disease

D TRABATTONI… - The Journal of …, 2009 - American Association of …